Miragen Therapeutics Inc (MGEN) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Miragen Therapeutics Inc   (NASDAQ: MGEN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Miragen Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MGEN Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 53.77 % 66.76 % 45.16 %
Gross Margin (Q2 TTM) 31.88 % 60.38 % 68.39 % 47.07 %
Gross Profit Margin 5 Yr. Avg. - 39.41 % 64.12 % 44.61 %
EBITDA Margin (Q2 MRQ) 0 % 15.55 % 20.73 % 14.8 %
EBITDA Margin (Q2 TTM) -2112.33 % 13.05 % 20.44 % 15.76 %
EBITDA Margin 5 Yr. Avg. --563.39 % 14.24 % 20.31 % 21.31 %
Operating Margin (Q2 MRQ) -44460.56 % 7.3 % 11.81 % 8.64 %
Operating Margin (Q2 TTM) -46455.22 % 5.42 % 15.58 % 10.98 %
Operating Margin 5 Yr. Avg. --562.79 % 10.22 % 14.49 % 14.74 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 5.92 % 9.43 % 5.89 %
Pre-Tax Profit Margin (Q2 TTM) -2263.57 % 3.12 % 10.84 % 6.75 %
Pre-Tax Profit Margin 5 Yr. Avg. - 6.53 % 10.83 % 10.99 %
Net Margin (Q2 MRQ) -44760.21 % 4.31 % 6.27 % 4.52 %
Net Margin (Q2 TTM) -45499.62 % 2.81 % 9.6 % 5.44 %
Net Margin 5 Yr. Avg. - 6.03 % 8.83 % 8.78 %